AI Prediction of Small-Airway Closure Patterns

Abstract

Small-airway closure is a critical yet underrecognized component of obstructive lung diseases that significantly impacts patient outcomes. Recent advances in artificial intelligence (AI) have revolutionized the prediction and characterization of small-airway closure patterns, presenting new diagnostic and management opportunities. This review synthesizes current evidence on the burden, pathophysiology, and clinical implications of small-airway closure, and evaluates AI-driven approaches for detection and prediction. Emphasis is placed on the integration of AI into clinical workflows, its impact on guideline recommendations, and the future scope for optimizing respiratory care.

Introduction

Small-airway disease constitutes a substantial, often covert, contributor to morbidity in various respiratory conditions, including asthma and chronic obstructive pulmonary disease (COPD). The clinical identification of small-airway closure remains challenging due to subtle presentation and limitations of conventional diagnostics. Artificial intelligence, through data-driven algorithms and machine learning, offers unparalleled potential to decipher complex physiological patterns and facilitate early, accurate prediction of small-airway closure. This review explores the current landscape of AI applications in small-airway closure, highlighting their clinical significance and transformative potential in respiratory medicine.

Epidemiology / Disease Burden

Small-airway dysfunction is implicated in up to 60–80% of patients with asthma and COPD, contributing to airflow limitation, hyperresponsiveness, and symptom exacerbation. Epidemiological studies demonstrate that small-airway closure is prevalent even in early disease stages and may precede overt spirometric abnormalities. The global disease burden is further underscored by the association of small-airway pathology with increased healthcare utilization, reduced quality of life, and heightened risk of acute exacerbations. Early identification and targeted intervention remain paramount to mitigate long-term morbidity.

Pathophysiology

Small-airway closure is characterized by premature collapse of distal bronchioles during tidal breathing, leading to ventilation heterogeneity and gas trapping. The mechanisms involve complex interplay between airway wall remodeling, inflammation, mucous plugging, and loss of elastic recoil. AI-driven pattern recognition leverages high-dimensional input from spirometry, oscillometry, and imaging to model these pathophysiological alterations. Machine learning algorithms can discern subtle deviations in airway resistance, reactance, and volume-time curves, enabling mechanistic insight into the onset and progression of small-airway closure.

Risk Factors

Major risk factors for small-airway closure include tobacco smoking, air pollution, occupational exposures, advancing age, and genetic predisposition. Comorbidities such as obesity, gastroesophageal reflux, and chronic rhinosinusitis further predispose individuals to small-airway dysfunction. AI models have demonstrated efficacy in stratifying risk by integrating multifactorial clinical, environmental, and genetic data, thus identifying high-risk cohorts for targeted surveillance and intervention.

Clinical Features

Patients with small-airway closure may present with nonspecific symptoms such as dyspnea on exertion, cough, and nocturnal wheezing. Notably, physical examination and standard spirometry may be unremarkable in early disease. Advanced pulmonary function tests, including impulse oscillometry and multiple breath washout, provide greater sensitivity but are not widely available. AI-enabled analysis of clinical and physiological data augments the detection of subtle symptom patterns and early functional impairment, improving diagnostic precision.

Diagnosis

Traditional diagnostic approaches rely on spirometric indices (e.g., FEF25–75%) and specialized techniques such as inert gas washout and imaging. However, these methods are limited by variability and accessibility. AI models trained on large datasets can enhance diagnostic performance by recognizing composite patterns across multiple modalities, including electronic health records, high-resolution CT, and advanced pulmonary function tests. Recent studies report that AI-based prediction tools outperform conventional algorithms in sensitivity and specificity for small-airway closure, supporting their integration into routine clinical practice.

Treatment & Management

Management strategies for small-airway closure focus on reducing airway inflammation, preventing remodeling, and optimizing bronchodilation. Inhaled corticosteroids and long-acting bronchodilators remain the mainstays of therapy. The application of AI in treatment planning enables personalized regimens by predicting therapeutic response based on individual airway closure patterns and comorbidities. Emerging digital platforms utilize AI algorithms to monitor disease progression, adherence, and exacerbation risk, thus facilitating proactive and adaptive management.

Recent Advances / Emerging Therapies

Recent advances include the development of deep learning models capable of extracting fine-grained airway features from CT scans and integrating them with functional data for comprehensive assessment. AI-powered digital stethoscopes and wearable sensors enable continuous monitoring of respiratory physiology, providing real-time feedback on airway dynamics. Furthermore, AI-guided drug development is accelerating the identification of novel therapeutic targets for small-airway diseases. Ongoing research into explainable AI aims to enhance clinician trust and interpretability of model predictions, supporting widespread adoption in clinical settings.

Guideline Recommendations

Current respiratory society guidelines acknowledge the significance of small-airway dysfunction in chronic airway diseases, yet specific recommendations for AI-driven prediction and monitoring are emerging. Leading organizations advocate for the integration of validated AI tools into diagnostic and management algorithms, with emphasis on data quality, transparency, and patient safety. Multidisciplinary collaboration is essential to establish standardized protocols, ensure ethical use, and optimize patient outcomes.

Conclusion

AI-based prediction of small-airway closure patterns represents a paradigm shift in pulmonary medicine, offering unprecedented accuracy and early detection capabilities. By harnessing advanced analytics and integrating multidimensional data, AI enhances diagnostic precision, informs personalized therapy, and supports guideline-driven care. Continued research, rigorous validation, and responsible implementation will be critical to fully realize the clinical benefits of AI in small-airway disease management.